Cargando…
Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients
BACKGROUND: New treatment modalities are needed for the treatment of cancers of the head and neck region (HNSCC). Survivin is important for the survival and proliferation of tumor cells and may therefore provide a target for immunotherapy. Here we focused on the ex vivo presence and in vitro inducti...
Autores principales: | Turksma, Annelies W, Bontkes, Hetty J, Ruizendaal, Janneke J, Scholten, Kirsten BJ, Akershoek, Johanneke, Rampersad, Shakila, Moesbergen, Laura M, Cillessen, Saskia AGM, Santegoets, Saskia JAM, de Gruijl, Tanja D, Leemans, C René, Meijer, Chris JLM, Hooijberg, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695847/ https://www.ncbi.nlm.nih.gov/pubmed/23787039 http://dx.doi.org/10.1186/1479-5876-11-152 |
Ejemplares similares
-
IL-21 in cancer immunotherapy: At the right place at the right time
por: Santegoets, Saskia JAM, et al.
Publicado: (2013) -
Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer
por: Scholten, Kirsten BJ, et al.
Publicado: (2011) -
Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors
por: Bontkes, Hetty J., et al.
Publicado: (2005) -
Priming of PRAME- and WT1-specific CD8(+) T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapy
por: van den Ancker, Willemijn, et al.
Publicado: (2013) -
IL-21 promotes the expansion of CD27(+)CD28(+) tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells
por: Santegoets, Saskia JAM, et al.
Publicado: (2013)